{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:05:49Z","timestamp":1757617549205,"version":"3.44.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00108-025-01869-6","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T11:18:45Z","timestamp":1741000725000},"page":"695-701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fibrosierende Erkrankungen im Gastrointestinaltrakt","Fibrotic diseases in the gastrointestinal tract"],"prefix":"10.1007","volume":"66","author":[{"given":"Elke","family":"Roeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"issue":"1","key":"1869_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1055\/s-2006-927388","volume":"45","author":"M Roderfeld","year":"2007","unstructured":"Roderfeld\u00a0M, Hemmann\u00a0S, Roeb\u00a0E (2007) Mechanisms of fibrinolysis in chronic liver injury (with special emphasis on MMPs and TIMPs). Z\u00a0Gastroenterol 45(1):25\u201333","journal-title":"Z Gastroenterol"},{"key":"1869_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","volume":"68\u201369","author":"E Roeb","year":"2018","unstructured":"Roeb\u00a0E (2018) Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol 68\u201369:463\u2013473","journal-title":"Matrix Biol"},{"issue":"3","key":"1869_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva\u00a0T, Brenner\u00a0D (2021) Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 18(3):151\u2013166","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"1869_CR4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jhep.2022.05.033","volume":"77","author":"A De Gottardi","year":"2022","unstructured":"De Gottardi\u00a0A, Sempoux\u00a0C, Berzigotti\u00a0A (2022) Porto-sinusoidal vascular disorder. J\u00a0Hepatol 77(4):1124\u20131135","journal-title":"J Hepatol"},{"issue":"3","key":"1869_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","volume":"5","author":"-","year":"2020","unstructured":"GBD 2017 Cirrhosis Collaborators (2020) The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5(3):245\u2013266","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"1869_CR6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1055\/a-2309-6052","volume":"62","author":"E Roeb","year":"2024","unstructured":"Roeb\u00a0E, Canbay\u00a0A, Bantel\u00a0H, Bojunga\u00a0J, de Laffolie\u00a0J, Demir\u00a0M, Denzer\u00a0UW, Geier\u00a0A, Hofmann\u00a0WP, Hudert\u00a0C et\u00a0al (2024) Neue Nomenklatur zur MASLD (Metabolic Dysfunction Associated Steatotic Liver Disease; metabolische Dysfunktion assoziierte steatotische Lebererkrankung). Z\u00a0Gastroenterol 62(7):1077\u20131087","journal-title":"Z Gastroenterol"},{"issue":"9","key":"1869_CR7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1055\/a-1880-2283","volume":"60","author":"E Roeb","year":"2022","unstructured":"Roeb\u00a0E, Canbay\u00a0A, Bantel\u00a0H, Bojunga\u00a0J, de Laffolie\u00a0J, Demir\u00a0M, Denzer\u00a0UW, Geier\u00a0A, Hofmann\u00a0WP, Hudert\u00a0C et\u00a0al (2022) Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) \u2013 April 2022 \u2013 AWMF-Registernummer: 021-025. Z\u00a0Gastroenterol 60(9):1346\u20131421","journal-title":"Z Gastroenterol"},{"issue":"1","key":"1869_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek\u00a0J, Chan\u00a0KE, Wong\u00a0ZY, Tan\u00a0C, Tan\u00a0B, Lim\u00a0WH, Tan\u00a0DJH, Tang\u00a0ASP, Tay\u00a0P, Xiao\u00a0J et\u00a0al (2023) Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a\u00a0systematic review and meta-analysis. Lancet Gastroenterol Hepatol 8(1):20\u201330","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1869_CR9","doi-asserted-by":"crossref","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP et\u00a0al (2023) A\u00a0multisociety Delphi consensus statement on new fatty liver disease nomenclature. J\u00a0Hepatol","DOI":"10.1097\/HEP.0000000000000696"},{"issue":"2","key":"1869_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000519611","volume":"38","author":"E Roeb","year":"2022","unstructured":"Roeb\u00a0E (2022) Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A\u00a0Narrative Review. Visc Med 38(2):126\u2013132","journal-title":"Visc Med"},{"issue":"11","key":"1869_CR11","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1055\/s-0043-120199","volume":"55","author":"-","year":"2017","unstructured":"- (2017) Practice guideline autoimmune liver diseases\u2014AWMF-Reg. No. 021-27. Z\u00a0Gastroenterol 55(11):1135\u20131226","journal-title":"Z Gastroenterol"},{"key":"1869_CR12","doi-asserted-by":"publisher","first-page":"671640","DOI":"10.3389\/fphar.2021.671640","volume":"12","author":"P Acharya","year":"2021","unstructured":"Acharya\u00a0P, Chouhan\u00a0K, Weiskirchen\u00a0S, Weiskirchen\u00a0R (2021) Cellular Mechanisms of Liver Fibrosis. Front Pharmacol 12:671640","journal-title":"Front Pharmacol"},{"key":"1869_CR13","doi-asserted-by":"crossref","unstructured":"Roeb E (2023) Interleukin-13 (IL-13)\u2014A Pleiotropic Cytokine Involved in Wound Healing and Fibrosis. Int J Mol Sci 24(16)","DOI":"10.3390\/ijms241612884"},{"issue":"1","key":"1869_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/hep.23274","volume":"51","author":"M Roderfeld","year":"2010","unstructured":"Roderfeld\u00a0M, Rath\u00a0T, Voswinckel\u00a0R, Dierkes\u00a0C, Dietrich\u00a0H, Zahner\u00a0D, Graf\u00a0J, Roeb\u00a0E (2010) Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4\u2212\/\u2212 mice. Hepatology 51(1):267\u2013276","journal-title":"Hepatology"},{"key":"1869_CR15","doi-asserted-by":"crossref","unstructured":"Hempel F, Roderfeld M, Savai R, Sydykov A, Irungbam K, Schermuly R, Voswinckel R, K\u00f6hler K, Churin Y, Kiss L et\u00a0al (2019) Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice. Cells 8(10)","DOI":"10.3390\/cells8101210"},{"key":"1869_CR16","doi-asserted-by":"crossref","unstructured":"Roehlen N, Crouchet E, Baumert TF (2020) Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 9(4)","DOI":"10.3390\/cells9040875"},{"issue":"6","key":"1869_CR17","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/gutjnl-2011-300608","volume":"61","author":"M Roderfeld","year":"2012","unstructured":"Roderfeld\u00a0M, Rath\u00a0T, Pasupuleti\u00a0S, Zimmermann\u00a0M, Neumann\u00a0C, Churin\u00a0Y, Dierkes\u00a0C, Voswinckel\u00a0R, Barth\u00a0PJ, Zahner\u00a0D et\u00a0al (2012) Bone marrow transplantation improves hepatic fibrosis in Abcb4\u2212\/\u2212 mice via Th1 response and matrix metalloproteinase activity. Gut 61(6):907\u2013916","journal-title":"Gut"},{"issue":"5","key":"1869_CR18","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1053\/j.gastro.2020.09.065","volume":"160","author":"DC Rockey","year":"2021","unstructured":"Rockey\u00a0DC, Friedman\u00a0SL (2021) Fibrosis Regression After Eradication of Hepatitis\u00a0C Virus: From Bench to Bedside. Gastroenterology 160(5):1502\u20131520.e1501","journal-title":"Gastroenterology"},{"issue":"5","key":"1869_CR19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","volume":"46","author":"S Hemmann","year":"2007","unstructured":"Hemmann\u00a0S, Graf\u00a0J, Roderfeld\u00a0M, Roeb\u00a0E (2007) Expression of MMPs and TIMPs in liver fibrosis\u2014a\u00a0systematic review with special emphasis on anti-fibrotic strategies. J\u00a0Hepatol 46(5):955\u2013975","journal-title":"J Hepatol"},{"issue":"7","key":"1869_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1055\/a-1498-2512","volume":"59","author":"M Cornberg","year":"2021","unstructured":"Cornberg\u00a0M, Sandmann\u00a0L, Protzer\u00a0U, Niederau\u00a0C, Tacke\u00a0F, Berg\u00a0T, Glebe\u00a0D, Jilg\u00a0W, Wedemeyer\u00a0H, Wirth\u00a0S et\u00a0al (2021) S3-Leitlinie der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion \u2013 (AWMF-Register-Nr. 021-11). Z\u00a0Gastroenterol 59(7):691\u2013776","journal-title":"Z Gastroenterol"},{"issue":"11","key":"1869_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1055\/a-1226-1841","volume":"58","author":"C Sarrazin","year":"2020","unstructured":"Sarrazin\u00a0C, Zimmermann\u00a0T, Zeuzem\u00a0S (2020) Addendum zur S3-Leitlinie \u201eProphylaxe, Diagnostik und Therapie der Hepatitis-C-Virus-Infektion\u201c. Z\u00a0Gastroenterol 58(11):1107\u20131108","journal-title":"Z Gastroenterol"},{"issue":"3","key":"1869_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"-","year":"2022","unstructured":"- (2022) EASL Clinical Practice Guidelines on sclerosing cholangitis. J\u00a0Hepatol 77(3):761\u2013806","journal-title":"J Hepatol"},{"issue":"2","key":"1869_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","volume":"152","author":"F Rieder","year":"2017","unstructured":"Rieder\u00a0F, Fiocchi\u00a0C, Rogler\u00a0G (2017) Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases. Gastroenterology 152(2):340\u2013350.e346","journal-title":"Gastroenterology"},{"key":"1869_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fmed.2020.00167","volume":"7","author":"N Zidar","year":"2020","unstructured":"Zidar\u00a0N, Langner\u00a0C, Jerala\u00a0M, Bo\u0161tjan\u010di\u010d\u00a0E, Drobne\u00a0D, Toma\u017ei\u010d\u00a0A (2020) Pathology of Fibrosis in Crohn\u2019s Disease-Contribution to Understanding Its Pathogenesis. Front Med 7:167","journal-title":"Front Med"},{"key":"1869_CR25","doi-asserted-by":"publisher","first-page":"835005","DOI":"10.3389\/fimmu.2022.835005","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang\u00a0Y, Huang\u00a0B, Jin\u00a0T, Ocansey\u00a0DKW, Jiang\u00a0J, Mao\u00a0F (2022) Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy. Front Immunol 13:835005","journal-title":"Front Immunol"},{"issue":"6","key":"1869_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/1751-2980.12882","volume":"21","author":"S Bos","year":"2020","unstructured":"Bos\u00a0S, Laukens\u00a0D (2020) Metabolic modulation during intestinal fibrosis. J\u00a0Dig Dis 21(6):319\u2013325","journal-title":"J Dig Dis"},{"issue":"3","key":"1869_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/ibd\/izy331","volume":"25","author":"R Mao","year":"2019","unstructured":"Mao\u00a0R, Kurada\u00a0S, Gordon\u00a0IO, Baker\u00a0ME, Gandhi\u00a0N, McDonald\u00a0C, Coffey\u00a0JC, Rieder\u00a0F (2019) The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn\u2019s Disease. Inflamm Bowel Dis 25(3):421\u2013426","journal-title":"Inflamm Bowel Dis"},{"key":"1869_CR28","doi-asserted-by":"crossref","unstructured":"de Sousa TH, Magro F (2023) How to Evaluate Fibrosis in IBD? Diagnostics 13(13)","DOI":"10.3390\/diagnostics13132188"},{"issue":"1","key":"1869_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4132\/jptm.2022.11.02","volume":"57","author":"JM Park","year":"2023","unstructured":"Park\u00a0JM, Kim\u00a0J, Lee\u00a0YJ, Bae\u00a0SU, Lee\u00a0HW (2023) Inflammatory bowel disease-associated intestinal fibrosis. J\u00a0Pathol Transl Med 57(1):60\u201366","journal-title":"J Pathol Transl Med"},{"issue":"3","key":"1869_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41575-021-00543-0","volume":"19","author":"S D\u2019Alessio","year":"2022","unstructured":"D\u2019Alessio\u00a0S, Ungaro\u00a0F, Noviello\u00a0D, Lovisa\u00a0S, Peyrin-Biroulet\u00a0L, Danese\u00a0S (2022) Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nat Rev Gastroenterol Hepatol 19(3):169\u2013184","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"1869_CR31","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1055\/a-2309-6123","volume":"62","author":"A Sturm","year":"2024","unstructured":"Sturm\u00a0A, Atreya\u00a0R, Bettenworth\u00a0D, Bokemeyer\u00a0B, Dignass\u00a0A, Ehehalt\u00a0R, Germer\u00a0CT, Grunert\u00a0PC, Helwig\u00a0U, Horisberger\u00a0K et\u00a0al (2024) Aktualisierte S3-Leitlinie \u201eDiagnostik und Therapie des Morbus Crohn\u201c der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version\u00a04.1) \u2013 living guideline. Z\u00a0Gastroenterol 62(8):1229\u20131318","journal-title":"Z Gastroenterol"},{"issue":"4","key":"1869_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/ibd\/izac221","volume":"29","author":"C Schuler","year":"2023","unstructured":"Schuler\u00a0C, Foti\u00a0F, Perren\u00a0L, Mamie\u00a0C, Weder\u00a0B, Stokmaier\u00a0M, de Valli\u00e8re\u00a0C, Heuchel\u00a0R, Ruiz\u00a0PA, Rogler\u00a0G, Hausmann\u00a0M (2023) Deletion of Smad7 Ameliorates Intestinal Inflammation and Contributes to Fibrosis. Inflamm Bowel Dis 29(4):647\u2013660","journal-title":"Inflamm Bowel Dis"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01869-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:53:45Z","timestamp":1757141625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01869-6"}},"subtitle":["Leberfibrose und mehr","Liver fibrosis and more"],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1869"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01869-6","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"4 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"E.\u00a0Roeb war als Referentin f\u00fcr die Firmen Abbvie, Amgen, Falk Foundation, Gilead, Merz Therapeutics, MSD, PM Results, Takeda t\u00e4tig und erhielt Beraterhonorare von den Firmen Alexion, GlaxoSmithKline, Ipsen, Boehringer Ingelheim Pharma, Xcenda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}